FDA 'Priority Voucher' Program Comes Under Congressional Scrutiny

https://www.profitableratecpm.com/f4ffsdxe?key=39b1ebce72f3758345b2155c98e6709c

FDA 'Priority Voucher' Program Comes Under Congressional Scrutiny (MedPage Today) — Two members of Congress have launched an investigation into FDA Commissioner Marty Makary, MD, MPH, and his use of “priority vouchers” to speed drug approvals, suggesting that the voucher program “could undermine public trust…

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button